1. Home
  2. CGTX vs BOOM Comparison

CGTX vs BOOM Comparison

Compare CGTX & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • BOOM
  • Stock Information
  • Founded
  • CGTX 2007
  • BOOM 1965
  • Country
  • CGTX United States
  • BOOM United States
  • Employees
  • CGTX N/A
  • BOOM N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • BOOM Industrial Specialties
  • Sector
  • CGTX Health Care
  • BOOM Industrials
  • Exchange
  • CGTX Nasdaq
  • BOOM Nasdaq
  • Market Cap
  • CGTX 126.2M
  • BOOM 128.2M
  • IPO Year
  • CGTX 2021
  • BOOM N/A
  • Fundamental
  • Price
  • CGTX $1.70
  • BOOM $7.77
  • Analyst Decision
  • CGTX Strong Buy
  • BOOM Hold
  • Analyst Count
  • CGTX 3
  • BOOM 1
  • Target Price
  • CGTX $2.83
  • BOOM $8.50
  • AVG Volume (30 Days)
  • CGTX 3.3M
  • BOOM 212.8K
  • Earning Date
  • CGTX 11-12-2025
  • BOOM 11-03-2025
  • Dividend Yield
  • CGTX N/A
  • BOOM N/A
  • EPS Growth
  • CGTX N/A
  • BOOM N/A
  • EPS
  • CGTX N/A
  • BOOM N/A
  • Revenue
  • CGTX N/A
  • BOOM $619,580,000.00
  • Revenue This Year
  • CGTX N/A
  • BOOM N/A
  • Revenue Next Year
  • CGTX N/A
  • BOOM $2.72
  • P/E Ratio
  • CGTX N/A
  • BOOM N/A
  • Revenue Growth
  • CGTX N/A
  • BOOM N/A
  • 52 Week Low
  • CGTX $0.22
  • BOOM $5.78
  • 52 Week High
  • CGTX $3.83
  • BOOM $13.77
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 52.47
  • BOOM 51.36
  • Support Level
  • CGTX $1.29
  • BOOM $8.10
  • Resistance Level
  • CGTX $1.61
  • BOOM $8.57
  • Average True Range (ATR)
  • CGTX 0.14
  • BOOM 0.38
  • MACD
  • CGTX -0.01
  • BOOM -0.03
  • Stochastic Oscillator
  • CGTX 93.62
  • BOOM 34.53

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: